Search results
Results from the WOW.Com Content Network
Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]
For other psychiatric disorders, including anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder, there is early evidence to suggest the potential benefit of ketamine ...
A patient can choose between ketamine infusion therapy, where the patient takes a low dose of ketamine each session and sits at the clinic for about an hour; and ketamine-assisted therapy, during ...
“The highest standard is to do ketamine treatments in the context of the specialized type of psychotherapy called ketamine-assisted psychotherapy,” Feifel said. “A provider that also has a ...
Reid Robison (born September 1976 in Illinois) is an American board-certified psychiatrist known primarily for his work with psychedelic medicines.As an early adopter and researcher of the use of ketamine in psychiatry, Robison has made significant contributions to ketamine-assisted psychotherapy (KAP) and other treatment modalities using ketamine for mental health conditions.
The main rationale behind the use of ketamine-assisted psychotherapy is its recognition as an effective antidepressant. [1] [8] [22] [23] With depressive symptomology being a major co-morbid problem with trauma-related disorders, treating depression can help treat the trauma and provide opportunities for the therapist to address other issues.
With a wide variety of treatment methods, it can take time to find the one that works best for you. One type of therapy that has been gaining traction in the medical community is ketamine ...
Effects of MDMA-assisted psychotherapy can be observed up to 12 months after receiving 2-3 active sessions of moderate to high dose MDMA (75–125 mg). [14] It is important to note that given the difficulties with appropriate blinding in trials of MDMA- and psychedelic-assisted psychotherapy the results are likely overestimated.